XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Revenues:        
Recurring and other revenue $ 314,170 $ 244,962 $ 816,010 $ 620,827
Interest income on funds held for clients 25,687 1,008 50,135 2,877
Total revenues 339,857 245,970 866,145 623,704
Cost of revenues 95,714 75,538 270,333 209,608
Gross profit 244,143 170,432 595,812 414,096
Operating expenses:        
Sales and marketing 74,064 52,752 220,821 154,856
Research and development 42,323 25,670 123,445 74,024
General and administrative 47,379 44,632 145,872 119,448
Total operating expenses 163,766 123,054 490,138 348,328
Operating income 80,377 47,378 105,674 65,768
Other income (expense) 1,139 (311) 971 (800)
Income before income taxes 81,516 47,067 106,645 64,968
Income tax expense (benefit) 23,900 12,221 3,077 (10,663)
Net income 57,616 34,846 103,568 75,631
Other comprehensive income (loss), net of tax 1,919 (1,218) 63 (1,628)
Comprehensive income $ 59,535 $ 33,628 $ 103,631 $ 74,003
Net income per share:        
Basic (in dollars per share) $ 1.03 $ 0.63 $ 1.86 $ 1.38
Diluted (in dollars per share) $ 1.02 $ 0.62 $ 1.83 $ 1.34
Weighted-average shares used in computing net income per share:        
Basic (in shares) 55,788 55,114 55,653 54,996
Diluted (in shares) 56,555 56,367 56,560 56,437